These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18783292)

  • 21. Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients.
    de Bruin EC; Whiteley JL; Corcoran C; Kirk PM; Fox JC; Armisen J; Lindemann JPO; Schiavon G; Ambrose HJ; Kohlmann A
    PLoS One; 2017; 12(5):e0175779. PubMed ID: 28472036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
    Hafner C; Landthaler M; Vogt T
    Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A protein-targeting strategy used to develop a selective inhibitor of the E17K point mutation in the PH domain of Akt1.
    Deyle KM; Farrow B; Qiao Hee Y; Work J; Wong M; Lai B; Umeda A; Millward SW; Nag A; Das S; Heath JR
    Nat Chem; 2015 May; 7(5):455-62. PubMed ID: 25901825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT1 and Ras/Akt pathways.
    Zhang JG; Zhao G; Qin Q; Wang B; Liu L; Liu Y; Deng SC; Tian K; Wang CY
    Pancreatology; 2013; 13(2):140-6. PubMed ID: 23561972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Akt kinase-interacting protein 1, a scaffold protein of the PI3K/PDK1/Akt pathway, in pancreatic cancer.
    Ohtsubo K; Yamada T; Zhao L; Jin TF; Takeuchi S; Mouri H; Yamashita K; Yasumoto K; Fujita N; Kitagawa H; Ohta T; Ikeda H; Yano S
    Pancreas; 2014 Oct; 43(7):1093-100. PubMed ID: 25036909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of E17K mutation in the pleckstrin homology domain of AKT1 in gastrointestinal and liver cancers in the Korean population.
    Cao Z; Song JH; Kim CJ; Cho YG; Kim SY; Nam SW; Lee JY; Park WS
    APMIS; 2008 Jun; 116(6):530-3. PubMed ID: 18754328
    [No Abstract]   [Full Text] [Related]  

  • 28. HSP27 expression in primary colorectal cancers is dependent on mutation of KRAS and PI3K/AKT activation status and is independent of TP53.
    Ghosh A; Lai C; McDonald S; Suraweera N; Sengupta N; Propper D; Dorudi S; Silver A
    Exp Mol Pathol; 2013 Feb; 94(1):103-8. PubMed ID: 22982087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer associated E17K mutation causes rapid conformational drift in AKT1 pleckstrin homology (PH) domain.
    Kumar A; Purohit R
    PLoS One; 2013; 8(5):e64364. PubMed ID: 23741320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer.
    Kinugasa H; Nouso K; Miyahara K; Morimoto Y; Dohi C; Tsutsumi K; Kato H; Matsubara T; Okada H; Yamamoto K
    Cancer; 2015 Jul; 121(13):2271-80. PubMed ID: 25823825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cucurmosin induces apoptosis of BxPC-3 human pancreatic cancer cells via inactivation of the EGFR signaling pathway.
    Zhang B; Huang H; Xie J; Xu C; Chen M; Wang C; Yang A; Yin Q
    Oncol Rep; 2012 Mar; 27(3):891-7. PubMed ID: 22139427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations.
    Zenz T; Döhner K; Denzel T; Döhner H; Stilgenbauer S; Bullinger L
    Br J Haematol; 2008 May; 141(5):742-3. PubMed ID: 18410456
    [No Abstract]   [Full Text] [Related]  

  • 33. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
    Zhao Z; Li C; Xi H; Gao Y; Xu D
    Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic myeloid leukemia and BCR/ABL signal pathways are not associated with AKT1 pleckstrin homology domain (E17K) mutations.
    He Y; Zheng J; Hu Y; Xiao H; Liu J; Li X; Du W; Chen X; Hu Y; Huang S
    Eur J Haematol; 2010 Jan; 84(1):87-8. PubMed ID: 19744127
    [No Abstract]   [Full Text] [Related]  

  • 37. A computational approach for investigating the mutational landscape of RAC-alpha serine/threonine-protein kinase (AKT1) and screening inhibitors against the oncogenic E17K mutation causing breast cancer.
    Thirumal Kumar D; Jain N; Evangeline J; Kamaraj B; Siva R; Zayed H; George Priya Doss C
    Comput Biol Med; 2019 Dec; 115():103513. PubMed ID: 31698236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias.
    Mahmoud IS; Sughayer MA; Mohammad HA; Awidi AS; EL-Khateeb MS; Ismail SI
    Br J Cancer; 2008 Aug; 99(3):488-90. PubMed ID: 18665177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.